FADS1 and brain cancer: Interestingly, the higher FADS1 expression was significantly associated with better OS (HR=0.702; 95% CI 0.604-0.816; P<0.001) and DFS (HR=0.706; 95% CI 0.615-0.809; P<0.001) among all brain cancers which include Lower grade glioma (LGG) and Glioblastoma multiforme (GBM).